I am...
- All
- HLH/FEL/FHL
- LCH
- Rare Histiocytic Disorders and Other Topics
- RDD
MEK Inhibition in the Therapy of Histiocytic Neoplasms
Principal Investigator Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center New York, New York USA Date of…
Identification of Molecular Mechanisms Underlying Defective Cytotoxic Lymphocyte Function in Chediak-Higashi Syndrome, a Histiocytic Lysosomal Storage Disorder with Immunodeficiency
Principal Investigator Konrad Krzewski, PhD National Institute of Allergy and Infectious Diseases, National Institutes of Health Rockville,…
Genetic Dissection of the Exocytic Machinery in Cytotoxic Lymphocytes
Principal Investigator Matthias Voss, PhD Karolinska Institutet Stockholm, Sweden Date of Award December 2015 Amount of…
Deciphering the Underlying Molecular Defects in CTL and NK Cell Cytotoxicity in FHL Patients
Principal Investigator Claudio Giraudo, PhD The Children’s Hospital of Philadelphia University of Pennsylvania Philadelphia, Pennsylvania USA Date…
The Interplay of NOTCH and MAPK Pathway in LCH
Principal Investigator Raphaela Schwentner, MSc, PhD Children’s Cancer Research Institute Vienna, Austria Date of Award December…
LCH-IV Clinical Trial – Stratum I Patient Registration Reimbursement for North American Institutions
Principal Investigator Carlos Rodriguez-Galindo, MD St. Jude Children’s Research Hospital Memphis, Tennessee USA Date of Award…